Related Experiment Videos
Is there an upper age limit for bone marrow transplantation?
1Division of Hematology and Bone Marrow Transplantation, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Bone Marrow Transplantation
|March 16, 2002
Summary
Hematopoietic cell transplantation is now less toxic, allowing for personalized treatment decisions. Patient suitability for transplantation should be based on physiological health, not just chronological age.
Area of Science:
- Hematology
- Transplantation Medicine
Background:
- Hematopoietic cell transplantation (HCT) encompasses both allogeneic and autologous procedures.
- Significant advancements have led to reduced toxicity in HCT.
Purpose of the Study:
- To emphasize individualized patient assessment for HCT feasibility.
- To advocate for physiological age as the primary determinant for HCT candidacy.
Main Methods:
- Review of recent advancements in HCT protocols.
- Analysis of patient outcomes based on physiological versus chronological age.
Main Results:
- Reduced toxicity observed in both allogeneic and autologous transplantation.
- Physiological age is a more accurate predictor of HCT success than chronological age.
Conclusions:
- Individualized assessment is crucial for determining HCT eligibility.
- Focusing on physiological age optimizes patient selection and outcomes in HCT.